Previous AMR Accelerator Events

28 September 2021
2nd IMI AMR Accelerator Annual Meeting

2nd IMI AMR Accelerator Annual Meeting

The 2nd Annual meeting for the Cross-IMI AMR Accelerator community will take place on 28 September as a digital event. Registration for both main session and breakout sessions via the link provided by personal e-mail invitation only is required. Details about the programme can be found in the agenda below.  

Find out more »
22 June 2021
Tuberculosis, a key research area of focus within the AMR Accelerator

Tuberculosis, a key research area of focus within the AMR Accelerator

The first part of this TB research focused webinar will introduce UNITE4TB, the newest member of the AMR Accelerator. The second part will discuss and address the challenges of the TB research community. We will discuss the fit of the current TB focused portfolio of projects with the global TB community and pipeline. Further activities […]

Find out more »
26 May 2021
GNA NOW Open Call webinar II

GNA NOW Open Call webinar II

GNA NOW Open Call webinar II  In case you missed the first webinar on 12 May, this is your second chance to attend the GNA NOW Open Call webinar and ask questions to Project Lead Eric Bacqué of Evotec and Project Coordinator Kristina Orrling of Lygature. The GNA NOW Consortium is looking for a novel […]

Find out more »
25 May 2021
Introduction to tools to help expertise sharing and collaboration in the AMR Accelerator community

Introduction to tools to help expertise sharing and collaboration in the AMR Accelerator community

  This webinar will cover the use of knowledge management tools in the IMI AMR Accelerator and how these can be used to both enhance data analysis workflows and also promote collaborations across projects and teams. To support these efforts the AMR Data Management group have developed a set of database and visualisation tools based […]

Find out more »
12 May 2021
WEBINAR: GNA NOW OPEN CALL

WEBINAR: GNA NOW OPEN CALL

Join us for this online webinar on Wednesday 12 May and find out about a unique opportunity for the antibiotic community. The Innovative Medicines Initiative's GNA NOW Consortium is looking for a novel antibiotic compound to progress to a clinical candidate. To find out more about what the Consortium is looking for, what’s in it […]

Find out more »
27 April 2021
EXPERT WORKSHOP: Advancing towards a standardized murine model to evaluate treatments for AMR lung infections

EXPERT WORKSHOP: Advancing towards a standardized murine model to evaluate treatments for AMR lung infections

The COMBINE project is part of the IMI AMR Accelerator. One of the scientific aims of COMBINE is to improve and standardize the pneumonia animal model used in AMR research and to develop improved tools to reliably translate results in animals into results in humans. Aim of the workshop: This workshop will address the need […]

Find out more »
08 February 2021
Expert Workshop on Vaccines for AMR Pathogens
28 January 2021
Tools for working with sensitive and clinical data in the AMR Accelerator: Ethics; templates and software infrastructure
03 December 2020
Online event: Keynote on AMR and TB by Peter Warn at COMBINE Annual Meeting

Online event: Keynote on AMR and TB by Peter Warn at COMBINE Annual Meeting

December 3, 2020, 3.30PM-4.30PM CET Peter Warn is an experienced antimicrobial discovery scientist and consultant with a long and successful record of working in the anti-infective discovery industry. His expertise goes from antimicrobial development (antibacterial, anti-fungal, anti-parasitic and anti Mtb), including in vitro, and animal models from basic models through to PKPD and assisting in […]

Find out more »
18 November 2020
Webinar: Animal infection models to study antibiotics against gram-negative bacteria

Webinar: Animal infection models to study antibiotics against gram-negative bacteria

This webinar will provide an overview of animal infection models commonly used for studies of antibiotics against gram-negative bacteria. The webinar is driven by the COMBINE objective to harmonize and standardize a protocol for a mouse infection model used for efficacy and PKPD studies. The infection model will be validated through well-characterized bacterial strains and […]

Find out more »